Literature DB >> 18094810

Lombard's effect's implication in intensity, fundamental frequency and stability on the voice of individuals with Parkinson's disease.

Araken Quedas1, André de Campos Duprat, Gisele Gasparini.   

Abstract

UNLABELLED: Parkinson's disease affects the central nervous system resulting in voice quality alterations. It is typically resistant to drug therapy and often persists despite extensive behavioural speech and language therapy. Previous findings show that masking noise will produce a consistent increase in voice intensity in most normal individuals (Lombard's effect). AIM: we evaluated Lombard's effect's implication in intensity, fundamental frequency and stability on the voice of individuals with Parkinson's disease (N=17).
MATERIAL AND METHODS: through acoustic analysis, we evaluated intensity alterations and fundamental frequency, before and after white masking noise 40, 70 and 90 dBSL intensities, as well as variations during each vocalization and compared with a control group (N=16).
RESULTS: voice intensity varied according to masking intensity, tending to non-linear increases in both groups and gender. Fundamental frequency varied, tending to non-linear increase in both groups and gender. Improvement stability occurred in fundamental frequency and vocal intensity.
CONCLUSION: Lombard's effect increased intensity, fundamental frequency and improves voice stability on these patients. STUDY: clinical and experimental.

Entities:  

Mesh:

Year:  2007        PMID: 18094810      PMCID: PMC9445896          DOI: 10.1016/s1808-8694(15)30129-4

Source DB:  PubMed          Journal:  Braz J Otorhinolaryngol        ISSN: 1808-8686


INTRODUCTION

Parkinson’s Disease (PD) was described in 1817 by an English Physician called James Parkinson, published with the title: “An assay on agitating paralysis”. It is a disease that affects the central nervous system, more specifically the neurons of the mesencephalic substantia nigra, responsible for releasing dopamine. A reduction in dopamine results in less inhibition of the basal nuclei’s activities, more precisely that of the corpus striatum, resulting in muscle rigidity, bradykinesia, tremor at rest and postural disorders. As far as speech is concerned, these patients have: intensity reduction (this is the major and most marked vocal alteration, it is progressive as the disease evolves), vocal instability, monotones, qualitative alterations such as tremor, hoarseness and pitch alterations, difficulties to start a phrase, articulatory alterations, accelerated speech and words repetition in an unconscious and uncontrolled way. This set of alterations is called hypokinetic dysarthria or disartrophonia2, 3, 4, 5, 6, 7, 8. As an alternative to reduce the complaints of hypophonia in these patients, some authors have used auditory masking with the aim of improving voice intensity11, 12. This method is known as the Lombard’s Effect, which makes it natural for the individual to speak louder, because of noise exposure, preventing him to hear it properly, or because of hearing loss. The mechanisms involved in this phenomenon are yet to be established. Lombard’s Effect (LE) was studied, and there was a marked improvement in voice intensity of these patients when submitted to auditory masking at 90dB SPL (decibels sound pressure level). Other authors also studied the LE’s repercussion on the voice of patients with Parkinson’s, submitting them to auditory masking with 10 and 20 dBSL (decibels sensation level), and they did not obtain the same results achieved by Adams, Lang (1992). The little information on this topic and the lack of agreement among the few papers available, about the method or the results attained, has triggered the interest for a study assessing the behavior of sound intensity and fundamental frequency, as well as voice utterance stability in this group of patients when exposed to auditory masking. Thus, this paper aimed at assessing, by means of an acoustic analysis, LE’s interference on the intensity and fundamental frequency in the voices of patients with PD, as well as the stability of each utterance.

MATERIALS AND METHODS

This study was approved by the Ethics Committee of our Institution, under protocol # 070/06.

Participants

We selected 33 participants: Patients with Parkinson’s (N=17, 8 men and 9 women) and the Control Group (N=16, 8 men and 8 women). All the participants freely signed the Informed Consent Form after being duly informed about the procedures.

Inclusion Criteria for the Parkinson’s Group

Patients diagnosed with idiopathic Parkinson’s Disease (PD), without other associated neurological disorders. Audiometric threshold averages equal to or below 20dB hearing level (dBHL) in the frequencies of 500, 1000 and 2000 Hz, in both ears. Have vocal quality between zero and one in the item: level of dysphonia, in the GRBAS scale13. Have language impairment level between zero and one in the Webster scale14 of PD disability assessment scale. Have general impairment level between stages one and two in the Hoehn and Yahr’s scale15. Use L-Dopa as drug treatment Age between 60 and 75 years.

Exclusion criteria for the Parkinson’s Group

We excluded those individuals who did not fit in items 1 to 7.

Control Group

We selected 16 individuals (8 women and 8 men) without auditory or vocal complaints, with ages varying between 60 and 75 years, who were later evaluated according to items 2 and 3 as inclusion criteria for this group.

Procedures

Auditory evaluation

We carried out tonal audiometry in the frequencies of 500, 1,000 and 2,000Hz in both ears.

Perceptive vocal assessment

An assessment, according to the GRBAS and Webster scales, carried out by three speech therapists and two otorhinolaryngologists, followed by the classification in each one of these scales, with the agreement of at least four evaluators.

Voice capture

Voice was captured directly to the computer by means of the Windows® sound recorder, with the microphone positioned laterally and at 5 cm from the individual’s mouth16. Each participant was submitted to uttering the vowel /a/, modal, without time control, in the following situations: without auditory masking, with auditory masking by broadband noise - “white noise”, binaural, simultaneous at 40, 70 and 90 decibels sensation level (dBSL).

Acoustic analysis

The data set collected was submitted to acoustic analysis by the voxmetria® software, in which we analyzed intensity variation in dB and the fundamental frequency in Hz of vocal utterance, before and after auditory masking, indirectly assessed by standard deviation within each utterance.

Statistical Analysis of the Data

For each parameter analyzed, we assessed the following factors: auditory masking intensity interference, the behavior of the Control and the Parkinson’s Groups, the behavior of males and females, the difference between the control and Parkinson’s groups, differences between males and females, and the behavior of gender and group factors when assessed simultaneously. The comparisons made between Parkinson and control were expressed as average and statistically analyzed by Repetitive Measures Variance Analysis. In all the tests, we used a significance level of 5% (p 0.05).

RESULTS

Intensity

Tables 1 and 2 show that vocal utterance intensity varies according to masking intensity (p<0.001), tending towards a non-linear increase (p<0.001). This increase is not influenced by Group (p=0.066) and nor by gender (p=0.683). There is no behavior difference between genders (p=0.240) nor between groups (p=0.430). When we compared both groups and genders simultaneously, behavior is similar (p=0.826). Such results show that, regardless of the group studied and gender, the trend is always of intensity increase. The graph represented in Figures 1, 2 and 3 show vocal utterance intensity behavior in the control and Parkinson’s Groups, as well as male and female genders.
Table 1

Utterance intensity average in dB, according to the auditory masking, by group and gender.

MaskingUtterance intensities mean values (dB)
Control Group
Parkinson’s Group
MaleFemaleTotalMaleFemaleTotal
0dB76,774,575,674,372,273,2
40dB79,075,077,177,072,874,9
70dB82,880,381,682,178,480,3
90dB86,285,185,787,583,785,6
Table 2

Vocal utterance intensity repetitive measures variance analysis.

Factorp value
Masking intensity< 0.001
Group interaction0.066
Gender interaction0.683
Group differences0.430
Gender differences0.240
Group x gender interaction0.826
Figure 1

Vocal utterance intensity (dB), according to auditory masking intensity in the Control and Parkinson’s Groups.

Figure 2

Vocal utterance intensity (dB), according to auditory masking intensity in the Control Group, males and females.

Figure 3

Vocal utterance intensity (dB), according to auditory masking intensity in the Parkinson’s Group, males and females.

Utterance intensity average in dB, according to the auditory masking, by group and gender. Vocal utterance intensity repetitive measures variance analysis. Vocal utterance intensity (dB), according to auditory masking intensity in the Control Group, males and females. Vocal utterance intensity (dB), according to auditory masking intensity in the Parkinson’s Group, males and females.

Intensity stability within each vocal utterance

This parameter was indirectly assessed through the intensity standard deviation within each vocal utterance. Tables 3 and 4 show that the intensity standard deviation within each vocal utterance varies according to masking intensity (p<0.001), tending towards a non-linear reduction (p<0.001). This reduction is not influenced by group (p=0.557), nor by gender (p=0.807). There is no behavior difference between the genders (p=0.180) nor between the groups (p=0.776). When compared both groups and genders simultaneously, behavior was similar (p=0.460). Thus, the results show a trend towards stability, with a more uniform vocal utterance as far as intensity is concerned. The graphs shown on Figures 4, 5 and 6 present the intensity standard deviation behavior in each utterance in the Control and Parkinson’s Groups, as well as in males and females.
Table 3

Mean values of the intensity standard deviations within each vocal utterance in dB, according to auditory masking by group and gender.

MaskingUtterance intensities standard deviation mean values (dB)
Control Group
Parkinson’s Group
MaleFemaleTotalMaleFemaleTotal
0dB2,41,92,12,62,32,5
40dB2,72,02,42,22,42,3
70dB1,91,81,92,21,82,0
90dB1,91,81,91,81,81,8
Table 4

Repetitive measures variance analysis for the intensity standard deviation within each vocal utterance.

Factorp Value
Masking intensity< 0.001
Group interaction0.557
Gender interaction0.807
Group differences0.776
Gender differences0.180
Group x gender interaction0.460
Figure 4

Vocal utterance intensity standard deviation (dB), according to auditory masking intensity, Control and Parkinson’s Group.

Figure 5

Vocal utterance intensity standard deviation (dB), according to auditory masking intensity, Control group, males and females.

Figure 6

Vocal utterance intensity standard deviation (dB), according to auditory masking intensity, Parkinson’s Group males and females.

Mean values of the intensity standard deviations within each vocal utterance in dB, according to auditory masking by group and gender. Repetitive measures variance analysis for the intensity standard deviation within each vocal utterance. Vocal utterance intensity standard deviation (dB), according to auditory masking intensity, Control and Parkinson’s Group. Vocal utterance intensity standard deviation (dB), according to auditory masking intensity, Control group, males and females. Vocal utterance intensity standard deviation (dB), according to auditory masking intensity, Parkinson’s Group males and females.

Vocal utterance frequency

Tables 5 and 6 show that vocal utterance frequency varies according to masking intensity (p<0.001), tending towards non-linear increase (p<0.001). This increase is not influenced by group (p=0.747) nor by gender (p=0.640). There is a behavior difference between genders (p<0.001), and it was higher for females. Repetitive measures variance analysis suggests a difference between groups (p=0.056), which was higher in the Parkinson’s group. When we compared both groups and gender simultaneously, the behavior was similar (p=0.201). This result means that, in both groups and genders there is an increase in vocal utterance frequency during exposure to auditory masking. The behavior in both the Control and Parkinson’s groups, as well as in males and females can be seen in the charts shown in Figures 7, 8 and 9.
Table 5

Utterance frequencies average in Hz, according to auditory masking, by group and gender.

MaskingUtterance frequencies average (Hz)
Control Group
Parkinson’s Group
MaleFemaleTotalMaleFemaleTotal
0dB126,6174,1150,4138,7210,2172,4
40dB130,1179,6154,9138,6211,4172,9
70dB137,9185,5161,7144,6219,1179,6
90dB156,3193,8175,1158,4233,6193,8
Table 6

Variance analysis of the repeated vocal utterance frequency.

Factorp Value
Masking intensity< 0.001
Group interaction0.747
Gender interaction0.640
Group differences0.056
Gender differences< 0.001
Group x gender interaction0.201
Figure 7

Vocal utterance frequency (Hz), according to auditory masking intensity, Control and Parkinson’s groups.

Figure 8

Vocal utterance frequency (Hz), according to auditory masking intensity, Control group, males and females.

Figure 9

Vocal utterance frequency (Hz), according to auditory masking intensity, Parkinson’s group, males and females.

Utterance frequencies average in Hz, according to auditory masking, by group and gender. Variance analysis of the repeated vocal utterance frequency. Vocal utterance frequency (Hz), according to auditory masking intensity, Control and Parkinson’s groups. Vocal utterance frequency (Hz), according to auditory masking intensity, Control group, males and females. Vocal utterance frequency (Hz), according to auditory masking intensity, Parkinson’s group, males and females.

Frequency stability within a given vocal utterance

This parameter was assessed indirectly through the frequency standard deviation within each vocal utterance. Tables 7 and 8 show that the frequency standard deviation within each vocal utterance varies according to masking intensity (p<0.001), tending towards non-linear reduction (p<0.001). This reduction occurs differently in the different groups (p=0.012) and genders (p=0.002). This behavior difference does not allow testing the differences between the Control and the Parkinson’s Group and between males and females. It is possible to suggest that there is a trend towards vocal utterance frequency stability. The graphs presented in Figures 10, 11 and 12 show different behavior between the Control and Parkinson’s groups, as it happens between males and females in both groups.
Table 7

Average value of frequency standard deviation within each vocal utterance in Hz, according to auditory masking, by group and gender.

MaskingMean values of the standard deviation in the utterance frequencies (Hz)
Control Group
Parkinson’s Group
MaleFemaleTotalMaleFemaleTotal
0dB2,73,73,23,78,86,1
40dB2,53,53,03,27,55,2
70dB2,63,63,13,04,83,9
90dB2,63,12,83,74,13,9
Table 8

Variance analysis of the frequency standard deviation measures within each vocal utterance.

Factorp Value
Masking intensity<0.001
Group interaction0.012
Gender interaction0.002
Group difference0.003
Gender difference0.002
Group x gender difference0.086
Figure 10

Vocal utterance frequency standard deviation (Hz), according to auditory masking intensity, Control and Parkinson’s groups.

Figure 11

Vocal utterance frequency standard deviation (Hz), according to auditory masking intensity, Control group, males and females.

Figure 12

Vocal utterance frequency standard deviation (Hz), according to auditory masking intensity, Parkinson’s group, males and females.

Average value of frequency standard deviation within each vocal utterance in Hz, according to auditory masking, by group and gender. Variance analysis of the frequency standard deviation measures within each vocal utterance. Vocal utterance frequency standard deviation (Hz), according to auditory masking intensity, Control and Parkinson’s groups. Vocal utterance frequency standard deviation (Hz), according to auditory masking intensity, Control group, males and females. Vocal utterance frequency standard deviation (Hz), according to auditory masking intensity, Parkinson’s group, males and females.

DISCUSSION

Voice neural control involves integration between the somatic motor system and the limbic system, involving fibers that go from the cortex, passing through the basal nuclei and by the mesencephalic substantia nigra. The basal nucleus plays an important role in modulating cortical impulses. Such modulation is reduced in PD, because of degeneration in the substantia nigra present at the base of the mesencephalus, involving not only dopaminergic neurons, but also other structures that produce serotonin, noradrenalin and acetylcholine in the genesis of the disease. The affected zone influences extra-pyramidal motor control, in other words, they control autonomous movements such as facial muscles (unconscious emotional communication), for example. Moreover, these neurons modify basic conscious commands coming from motor cortical neurons in a way to execute movements smoothly and without losing balance. It is also this extrapyramidal system that prevents continuous contraction or relaxation, and these events directly affect voice production20, 21. Thus, voice and speech difference, known as dysarthrophonia, represent an important set of signs and symptoms in PD. Traditional methods of phonotherapeutic treatment were not efficient to treat these alterations. Currently, LSVT® has been the most used technique, and the one showing the best results6, 21. Some authors have proposed some alternatives to improve these patients11, 12, 22, however, the only statistically proven method is LSVT®. This limited number of alternatives was the major driver for this study, and besides, the method proposed is simple to use and it can be improved in the future to be used in screening patients for treatment, indicating, for instance, those patients with better prognoses.

Discussion of the results

In order to facilitate results discussion, each parameter was analyzed separately.

Vocal utterance intensity

Utterance intensity increased in both groups evaluated and in both genders, matching results found in the literature9, 11, 23, 24, 25. This increase was progressive and proportional to the increase in masking that is offered, that is, the greater the masking, the greater will be vocal utterance intensity, in agreement with studies previously published (Figure 1, Figure 2, Figure 3)9, 11, 12, 26, 27, 28, 29, 30. Vocal utterance intensity (dB), according to auditory masking intensity in the Control and Parkinson’s Groups. However, the initial average intensity of auditory pre-masking utterance was reduced in the group with Parkinson’s when compared to the Control group (Figure 1), confirming hypophonia as an important characteristic in these individuals3, 5, 6, 11, 12, 31. All the individuals in the Parkinson’s group used levodopa or dopaminergic agonists as a pharmacologic measure. There is no consensus in the literature as to voice improvements with the use of levodopa and dopaminergic agonists. Some papers suggest that pharmacologic treatment does not bring about significant improvements in vocal traits31, 32. Others suggest that speech improvements due to medication use occur mainly with the symptoms related with joint and posture, considered dopamine-dependents, and were not very much felt in parameters such as tremor5, 33. There are those that advocate that drug treatment promotes significant speech improvements34, 35. In our study, although there has been an increase in voice intensity, both in auditory perception and through acoustic analysis, utterance intensity in the Parkinson’s group was less, suggesting that the “pharmacological treatment” factor, although bringing some voice improvement, is not enough to normalize patterns. Results suggest that, as it happens with vocal therapy, the goal in voice intensity increase is reached through LE6, 11, 12, 21, 22, 36.

Vocal Utterance Intensity Instability

This parameter was indirectly checked by means of a standard deviation pattern within each vocal utterance. It tended towards reduction in both groups, varying proportionally in relation to masking intensity. That is, the more intense the masking, the lower is the vocal utterance standard deviation. There was no behavior difference between Parkinson’s and the Control group. It is possible to visually perceive these findings (Figure 4). Such findings suggest that an increase in vocal utterance intensity improves stability in terms of intensity, and this improvement was similar in both groups. This is an important finding in patients with PD, since one of the characteristics of this group is the difficulty in maintaining vocal utterance stability during speech4, 5. There are no papers in the literature describing the use of this analysis parameter. Thus, the comments hereby made were based on acoustic and perception analysis findings, and on statistical analysis of the data.

Vocal Utterance Frequency

Utterance frequency increased in both groups assessed and in both genders. This increase was progressive and proportional to the increase in masking used, that is, the higher the masking, the greater the vocal utterance intensity reflecting in a higher fundamental frequency and a greater vocal utterance power. Average utterance frequency was greater in females, which did not confirm the findings from Holmes et al. (2000), who found a reduction in the fundamental frequency in women and an increase in men. Perception and auditory findings match the results from the acoustic analysis, also in disagreement from the findings by Holmes et al. (2000). A hypothesis that could explain this disagreement is the fact that patients in this study were in the initial stages of the disease, while those from the study aforementioned belonged to many stages of the disease. As to the fundamental frequency in these patients, literature is scarce, showing that their major interest is utterance intensity, followed by the alterations that mark the instability. In this sense, it is important to assess vocal utterance frequency in PD patients.

Vocal Utterance Frequency Stability

Just as it happened with vocal utterance intensity stability, this parameter was indirectly assessed by means of the fundamental frequency standard deviation within each vocal utterance. In both groups, this parameter tended to reduce, varying proportionally in relation to masking intensity. That is, the more intense the masking, the lower is vocal utterance frequency standard deviation. However, the behavior difference did not let us test differences between the Control and the Parkinson’s Groups as far as gender is concerned. It is possible to suggest that there is a trend towards vocal utterance frequency stability. The comments made hereby were based on evaluating the Graph (Figure 10) that represent the analysis of the parameter tested, assessing the behavior of both, the Control and the Parkinson’s Groups. The Graph (Figure 10) shows that the control group curve tends to be flatter, suggesting greater frequency stability in vocal utterance in this group. In the Parkinson’s group, values start high and tend to stabilize after masking with 70dBSL. This stability is important for total voice improvement in these patients4, 5. Literature has no paper describing the use of such analysis parameter. The comments hereby made were based on the findings of acoustic analyses, perception and auditory analysis, and data statistical analysis.

FINAL REMARKS

If we consider that speech mirrors our personalities, which is unique in its vibrations, tones and musicality, it becomes easier to understand how much these changes interfere in the daily activities of these patients and in their social relations. However, the means specifically created for language improvement in these patients are still limited, currently being restricted to LSVT®. Surgical treatment is still far from us. The “Deep Brain Stimulation”, whose goal is to reduce the activities of the globus pallidus, subthalamic nucleus and thalamus, is a great promise for these patients. Postoperative results have been very promising with important voice improvements, showing the way to a new therapeutic horizon39, 40, 41, 42. However, we have to take into account that this technology is not available to most of these patients, especially in a developing country like Brazil, thus the importance of developing innovative and accessible approaches that help in assessing and treating vocal symptoms in this group. Studies such as those from Adams, Lang (1992), and Angelis et al. (1997) and Ho et al. (1999) are highly important because, besides opening new therapeutic horizons, have fostered new studies in search of a better quality of life for this group.

CONCLUSION

The Lombard effect causes significant increase in vocal utterance fundamental frequency for individuals with Parkinson’s disease. Results also suggest an improvement in vocal utterance stability, both in terms of intensity and fundamental frequency. When we compare the results between the Control and the Parkinson’s Group, both present similar behavior, suggesting that the LE occur in both groups apparently in the same way.
  36 in total

1.  Can the Lombard effect be used to improve low voice intensity in Parkinson's disease?

Authors:  S G Adams; A E Lang
Journal:  Eur J Disord Commun       Date:  1992

Review 2.  The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia.

Authors:  C R Gerfen
Journal:  Annu Rev Neurosci       Date:  1992       Impact factor: 12.449

3.  Lombard reflex during PAG-induced vocalization in decerebrate cats.

Authors:  S Nonaka; R Takahashi; K Enomoto; A Katada; T Unno
Journal:  Neurosci Res       Date:  1997-12       Impact factor: 3.304

4.  Intensive speech treatment for patients with Parkinson's disease: short-and long-term comparison of two techniques.

Authors:  L O Ramig; S Countryman; C O'Brien; M Hoehn; L Thompson
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

Review 5.  Treatment efficacy: voice disorders.

Authors:  L O Ramig; K Verdolini
Journal:  J Speech Lang Hear Res       Date:  1998-02       Impact factor: 2.297

6.  Voice characteristics in the progression of Parkinson's disease.

Authors:  R J Holmes; J M Oates; D J Phyland; A J Hughes
Journal:  Int J Lang Commun Disord       Date:  2000 Jul-Sep       Impact factor: 3.020

7.  Laryngeal findings in advanced Parkinson's disease.

Authors:  Joel H Blumin; Dana E Pcolinsky; Joseph P Atkins
Journal:  Ann Otol Rhinol Laryngol       Date:  2004-04       Impact factor: 1.547

Review 8.  Deep brain stimulation for Parkinson's disease.

Authors:  D Panikar; A Kishore
Journal:  Neurol India       Date:  2003-06       Impact factor: 2.117

9.  Disorders of verbal expression in parkinsonism.

Authors:  M Streifler; S Hofman
Journal:  Adv Neurol       Date:  1984

10.  Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients.

Authors:  J A Logemann; H B Fisher; B Boshes; E R Blonsky
Journal:  J Speech Hear Disord       Date:  1978-02
View more
  3 in total

1.  Laryngeal Aerodynamics in Healthy Older Adults and Adults With Parkinson's Disease.

Authors:  Deborah Matheron; Elaine T Stathopoulos; Jessica E Huber; Joan E Sussman
Journal:  J Speech Lang Hear Res       Date:  2017-03-01       Impact factor: 2.297

2.  Vocal responses to perturbations in voice auditory feedback in individuals with Parkinson's disease.

Authors:  Hanjun Liu; Emily Q Wang; Leo Verhagen Metman; Charles R Larson
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

Review 3.  Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.

Authors:  Clare P Herd; Claire L Tomlinson; Katherine H O Deane; Marian C Brady; Christina H Smith; Catherine M Sackley; Carl E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.